Abbott Laboratories (ABT)
30 Nov 2016
BRUSSELS The European Commission on Wednesday said it has given its conditional approval to U.S. medical device maker Abbott Laboratories' bid for peer St Jude Medical Inc .
BRUSSELS, Nov 23 The European Commission on Wednesday said it has given its conditional approval to U.S. medical device maker Abbott Laboratories' bid for peer St Jude Medical Inc.
(The following statement was released by the rating agency) CHICAGO, November 18 (Fitch) Fitch Ratings has assigned an 'A(EXP)' rating with a Negative Rating Watch to Abbott Laboratories' (ABT, Abbott) notes offering. The net proceeds are expected to be used to fund the company's acquisition of St. Jude Medical Inc. (STJ, St. Jude). Abbott is also in the process of potentially acquiring Alere Inc. (Alere). Fitch will resolve the Rating Watch as more details regarding the transaction become
EU antitrust regulators are expected to give conditional clearance to U.S. medical device maker Abbott Laboratories' $25 billion bid for rival St. Jude Medical Inc , a person familiar with the matter said on Tuesday.
Nov 15 The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Tuesday:
BRUSSELS, Nov 14 The following are mergers under review by the European Commission and a brief guide to the EU merger process:
* Abbott laboratories - japan has approved company's absorb bioresorbable heart stent Source text for Eikon: Further company coverage:
The 2nd U.S. Circuit Court of Appeals has rejected two drug wholesalers' appeal of an injunction barring them from selling in the U.S. blood glucose test strips made by Abbott Laboratories for overseas sale.
BRUSSELS, Nov 3 The following are mergers under review by the European Commission and a brief guide to the EU merger process:
BRUSSELS Medical device maker Abbott Laboratories has offered concessions in an attempt to secure EU antitrust approval for its $25 billion bid for St Jude Medical Inc , according to the European Commision.
|Johnson & Johnson (JNJ.N)||$111.30||--|
|Pfizer Inc. (PFE.N)||$32.14||--|
|Novartis AG (NOVN.S)||CHF69.30||-0.95|
|Merck & Co., Inc. (MRK.N)||$61.19||--|
|Sanofi SA (SASY.PA)||€74.94||-1.17|
|AstraZeneca plc (AZN.L)||4,091.00p||-58.50|
|GlaxoSmithKline plc (GSK.L)||1,465.50p||-30.00|
|Eli Lilly and Co (LLY.N)||$67.12||--|
|Amgen, Inc. (AMGN.OQ)||$144.07||--|
|Boston Scientific Corporation (BSX.N)||$20.46||--|